Letter: Adjuvant treatment of severe falciparum malaria, intravascular coagulation, and heparin.
D000962:Antimalarials / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000209:etiology*; D004341:Drug Evaluation; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008288:Malaria / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D010963:Plasmodium falciparum
D000962:Antimalarials; D003907:Dexamethasone; D006493:Heparin